Efficacy and safety of low-dose 15-methyl prostaglandin F2α for cervical ripening in the first trimester of pregnancy

Fernando Arias

doi:10.1016/0002-9378(84)90309-0

Efficacy and safety of low-dose 15-methyl prostaglandin F2α for cervical ripening in the first trimester of pregnancy

Fernando Arias

In: American Journal of Obstetrics and Gynecology · 1984 · vol. 149(1) , pp. 100–101 · doi:10.1016/0002-9378(84)90309-0 · PMID:6720761 · W2067866404

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-01 ⓘ

This study investigated the efficacy and safety of low-dose 15-methyl prostaglandin F2α for cervical ripening in the first trimester of pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero 1981

References (4)

Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero via openalex
doi:10.1016/0002-9378(79)90748-8 via openalex
doi:10.1016/0002-9378(82)90179-x via openalex
doi:10.1016/0002-9378(82)90770-0 via openalex

Source provenance

openalex: last seen: 2026-05-11T04:51:27.821502+00:00

License: CC0 · commercial use OK

[1] Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero 1981